Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
Holding IART?
Track your performance easily

Integra Lifesciences (IART) Financial Statements

221 Followers

Integra Lifesciences Financial Overview

Integra Lifesciences's market cap is currently ―. The company's EPS TTM is $0.295; its P/E ratio is 59.64; Integra Lifesciences is scheduled to report earnings on October 23, 2024, and the estimated EPS forecast is $0.39. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 418.18M$ 368.87M$ 382.42M$ 381.27M$ 380.85M
Gross Profit$ 225.92M$ 206.83M$ 218.34M$ 207.03M$ 232.87M
EBIT$ -15.19M$ 8.39M$ 31.67M$ 16.29M$ 41.88M
EBITDA$ 21.59M$ 38.96M$ 62.23M$ 47.11M$ 73.02M
Net Income Common Stockholders$ -12.40M$ -3.28M$ 19.50M$ 4.18M$ 24.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 296.90M$ 663.10M$ 273.73M$ 309.19M$ 307.37M
Total Assets$ 4.07B$ 4.08B$ 3.74B$ 3.78B$ 3.74B
Total Debt$ 2.01B$ 2.04B$ 1.69B$ 1.60B$ 1.51B
Net Debt$ 1.71B$ 1.38B$ 1.41B$ 1.29B$ 1.20B
Total Liabilities$ 2.54B$ 2.48B$ 2.16B$ 2.09B$ 2.07B
Stockholders Equity$ 1.53B$ 1.60B$ 1.58B$ 1.68B$ 1.67B
Cash Flow-
Free Cash Flow$ 10.69M$ 291.00K$ 11.49M$ 11.35M$ 7.75M
Operating Cash Flow$ 40.40M$ 15.76M$ 24.57M$ 26.90M$ 21.46M
Investing Cash Flow$ -322.20M$ -53.97M$ -5.50M$ -14.17M$ -9.01M
Financing Cash Flow$ -93.75M$ 358.68M$ -49.66M$ -10.69M$ -162.68M
Currency in USD

Integra Lifesciences Earnings and Revenue History

Integra Lifesciences Debt to Assets

Integra Lifesciences Cash Flow

Integra Lifesciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis